SLVP033, NCT03312699: Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort |
|
|
| Completed | 1 | 54 | US | Fluzone® quadrivalent, IIV4 inactivated influenza vaccine, Fluzone High Dose, High Dose Trivalent, inactivated influenza vaccine (TIV), Fluad, Adjuvanted Trivalent, inactivated influenza vaccine, Vaqta, Inactivated Hepatitis A Vaccine, Typhim Vi, Typhoid Vi Polysaccharide Vaccine, Vivotif, Typhoid Vaccine Live Oral Ty21a | Stanford University, National Institute of Allergy and Infectious Diseases (NIAID) | Influenza, Hepatitis A, Typhoid, Healthy Adults | 12/23 | 12/23 | | |
NCT05426174: Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older |
|
|
| Completed | 1 | 233 | US | mRNA NA vaccine, High Dose Quadrivalent Influenza Vaccine, Fluzone HD | Sanofi Pasteur, a Sanofi Company | Influenza Immunization, Healthy Volunteers | 01/24 | 01/24 | | |
NCT06229392: A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer |
|
|
| Recruiting | 1 | 18 | US | Fluzone Quadrivalent | Rush University Medical Center | Breast Cancer, Breast Cancer Triple Negative | 12/25 | 12/25 | | |
